
Journal of Pharmaceutical Innovation, Journal Year: 2025, Volume and Issue: 20(2)
Published: April 1, 2025
Language: Английский
Journal of Pharmaceutical Innovation, Journal Year: 2025, Volume and Issue: 20(2)
Published: April 1, 2025
Language: Английский
International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(7), P. 3015 - 3015
Published: March 26, 2025
Alzheimer's disease (AD) is a progressive neurodegenerative characterized by cognitive decline, memory loss, and behavioural changes. While genetic predispositions pathological processes have been the traditional focus, this review highlights fundamental role of environmental factors, particularly nutrition, within exposome framework in modulating risk progression AD. The exposome, which includes totality exposures an individual's lifetime, provides comprehensive approach to understanding complex aetiology In review, we explore impact dietary factors cyclic nucleotide pathways (cAMP/cGMP) on AD, emphasizing potential interventions as therapeutic strategies. We investigate key aspects how nutrition affects accumulation β-amyloid, aggregation tau proteins, neuroinflammation. also examine specific nutrients performance Additionally, discuss nutraceuticals with anti-phosphodiesterase activity various animal models AD (such 5xFAD, 3xTg-AD, Tg2576, APP/PS1 mice) demonstrating effects onset progression.
Language: Английский
Citations
0Journal of Pharmaceutical Innovation, Journal Year: 2025, Volume and Issue: 20(2)
Published: April 1, 2025
Language: Английский
Citations
0